Danaher Corporation (DHR)

NYSE: DHR · IEX Real-Time Price · USD
256.83
+1.65 (0.65%)
At close: Jun 24, 2022 4:06 PM
256.99
+0.16 (0.06%)
After-hours: Jun 24, 2022 7:55 PM EDT
0.65%
Market Cap 186.74B
Revenue (ttm) 30.28B
Net Income (ttm) 6.29B
Shares Out 727.08M
EPS (ttm) 8.64
PE Ratio 29.73
Forward PE 23.70
Dividend $0.92 (0.36%)
Ex-Dividend Date Jun 23, 2022
Volume 2,780,826
Open 255.61
Previous Close 255.18
Day's Range 253.73 - 257.34
52-Week Range 233.71 - 333.96
Beta 0.84
Analysts Buy
Price Target 334.98 (+30.4%)
Earnings Date Jul 21, 2022

About DHR

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filt... [Read more...]

Industry Health Care Equipment & Supplies
Founded 1969
CEO H. Lawrence Culp
Employees 78,000
Stock Exchange NYSE
Ticker Symbol DHR
Full Company Profile

Financial Performance

In 2021, Danaher's revenue was $29.45 billion, an increase of 32.17% compared to the previous year's $22.28 billion. Earnings were $6.43 billion, an increase of 76.44%.

Financial Statements

Analyst Forecast

According to 28 analysts, the average rating for DHR stock is "Buy." The 12-month stock price forecast is 334.98, which is an increase of 30.43% from the latest price.

Price Target
$334.98
(30.43% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Danaher (DHR) Exhibits Bright Prospects, Headwinds Persist

Danaher (DHR) gains from solid demand for its products, acquired assets and shareholder-friendly policies. However, escalating costs and high debt levels remain concerns.

Find businesses consumers have a harder time trading down, says FBB's Mike Bailey's

Mike Bailey, FBB Capital Partners director of research, joins 'Power Lunch' to discuss overcoming market fears and finding opportunities in a volatile market.

Other symbols: CLXGOOGL

Danaher Schedules Second Quarter 2022 Earnings Conference Call

WASHINGTON , June 21, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 be...

The 7 Safest Blue-Chip Stocks You Can Buy Now

The safest blue-chip stocks have strong catalysts bolstering their upside. As inflation soars, investing in these stocks makes more sense.

Other symbols: LMTMSFTPEPRTXTJXUL

MARUY or DHR: Which Is the Better Value Stock Right Now?

MARUY vs. DHR: Which Stock Is the Better Value Option?

Other symbols: MARUY

5 High-Performing Stocks Ron Baron and Daniel Loeb Both Own

According to the All-in-One Screener, a Premium feature of GuruFocus, five stocks that Ron Baron (Trades, Portfolio) and Daniel Loeb (Trades, Portfolio) both agree on and have outperformed the Standard ...

Other symbols: IACCMCGTDGUNH

Two-minute drill: ADBE, DHR & CCI

Ayako Yoshioka, Wealth Enhancement Group senior portfolio manager, joins 'Closing Bell: Overtime' to discuss some of her top names for investors' portfolios in the current environment.

Other symbols: ADBECCI

7 Blue-Chip Stocks to Buy for June 2022

Blue-chip stocks are a smart choice during times when economic uncertainty is expected. So, here are seven blue-chip stocks to buy right now.

Other symbols: CVXLMTMCDMSFTTUPS

SCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- #ASMS--SCIEX launches the next generation of Data Independent Acquisition with Zeno SWATH DIA at ASMS 2022.

SCIEX Launches the New Cornerstone of Software Ecosystem - SCIEX OS 3.0

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- #ASMS--SCIEX launches the new cornerstone of software ecosystem - SCIEX OS 3.0 - featuring Zeno SWATH DIA, stMRM and accessibility across 9 languages.

Top Wall Street analysts are gaining more confidence in these stocks

TipRanks analyst ranking service pinpoints Wall Street's picks for best-performing stocks, including Nvidia and Marvell.

Other symbols: COPMRVLNVDAWDAY

Billionaire Dan Loeb Is Betting Big on These 3 Stocks

Dan Loeb is a veteran hedge fund manager and the CEO of Third Point. Let's take a look at his top three positions as of Q1.

Other symbols: PCGS

MS Global Franchise Portfolio's Top 5 1st-Quarter Buys

The MS Global Franchise Portfolio (Trades, Portfolio), part of Morgan Stanley's ( MS , Financial) mutual funds, disclosed in a regulatory filing that its top five buys during the first quarter included ...

Other symbols: EFXMSNKEOTIS

MARUY vs. DHR: Which Stock Is the Better Value Option?

MARUY vs. DHR: Which Stock Is the Better Value Option?

Other symbols: MARUY

Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

Consortium aims to speed the development and delivery of customized or 'bespoke' gene therapies WASHINGTON , May 12, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it has joined the...

The fundamentals are in good shape for Danaher, says FBB Capital Partners' Mike Bailey

Mike Bailey, FBB Capital Partners director of research, joins 'Power Lunch' to discuss the FAANG 'survivors,' companies that are compelling at these lower levels and more.

DANAHER ANNOUNCES QUARTERLY DIVIDENDS

WASHINGTON , May 10, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common stoc...

RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics

FRAMINGHAM, Mass.--(BUSINESS WIRE)-- #EL--At TIDES 2022, SCIEX, a global leader in life science analytical technologies, and a company of Danaher Corporation (NYSE:DHR), launches the RNA 9000 Purity & I...

Down 25% in 2022: Buy This High-Quality Stock on a Dip?

Danaher's long-term prospects are being ignored because of the near-term speculation around how long the pandemic will last.

Danaher To Present At Bank Of America Securities Health Care Conference

WASHINGTON , May 4, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Healt...

Buy 'gift horse' Danaher while it's down but leave room for other stocks, Cramer says

The "Mad Money" host explained why investors should act fast to purchase Danaher stock on Friday's episode of the show.

Will Danaher reverse the trend of the declining share price after Q1 results?

Danaher Corporation (NYSE:DHR) had several weeks of downward pressure on the price. The stock appears to have consolidated in the range between $262 and $297.

All You Need to Know About Danaher (DHR) Rating Upgrade to Buy

Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Danaher gets lift from Covid testing, but core business is also humming

We expect some noise around Covid testing quarter to continue as we work through China lockdowns, we think it's a distraction from Danaher's long-term story.

Danaher's (DHR) Q1 Earnings & Revenues Beat, Increase Y/Y

Danaher's (DHR) first-quarter 2022 revenues increase 12% year over year driven by impressive performance across its segments.